company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2948000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2948000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2948000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2008000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7320000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9328000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6380000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,27000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,119000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,92000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6288000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6288000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6288000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6288000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4100000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.52
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4100000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.52
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4135000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q1,2011-01-01,2011-03-31,2012-05-10 16:59:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.52
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1232000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1232000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1232000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1941000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7273000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9214000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7982000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,105000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,79000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7903000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7903000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7903000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7903000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4200000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-1.9
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4200000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-1.9
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4151000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q2,2011-04-01,2011-06-30,2012-08-10 13:33:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-1.9
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1441000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1441000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1441000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1772000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8321000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10093000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8652000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,117000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,95000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,16000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-8658000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8658000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8658000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8658000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4200000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-2.06
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4200000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-2.06
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4201000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q3,2011-07-01,2011-09-30,2012-11-13 16:31:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-2.06
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,26052000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,26052000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,26052000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,1894000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,5445000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,7339000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,18713000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,564000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,83000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-481000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,18232000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,18232000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,18232000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,18232000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,4200000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,4.38
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,4200000.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,4.38
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,4210704.0
ChemoCentryx Inc,CCXI,,0001340652,2011.0,Q4,2011-10-01,2011-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,4.38
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1018000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1018000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1018000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2562000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,6909000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,9471000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-8453000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,735000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,103000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-632000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9085000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9085000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9085000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9085000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,32400000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,32400000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,32931000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q1,2012-01-01,2012-03-31,2012-05-10 16:59:30+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1128000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1128000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1128000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2473000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9694000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12167000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11039000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,21000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,167000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,146000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10893000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10893000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10893000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10893000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36300000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36300000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36169000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q2,2012-04-01,2012-06-30,2012-08-10 13:33:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1128000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1128000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1128000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2619000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8746000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11365000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10237000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,20000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,141000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,121000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10116000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10116000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10116000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10116000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,-36100000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.28
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,-36100000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.28
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36180000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q3,2012-07-01,2012-09-30,2012-11-13 16:31:15+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.28
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2145000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2145000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2145000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2826000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9220000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12046000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9901000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,18000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,122000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,104000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9797000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9797000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9797000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9797000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,35300000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.83
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,35300000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.83
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,35407000.0
ChemoCentryx Inc,CCXI,,0001340652,2012.0,Q4,2012-10-01,2012-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.83
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1927000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1927000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1927000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2964000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9255000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12219000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10292000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,17000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,99000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10193000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10193000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10193000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10193000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,36400000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,36400000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,36611000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q1,2013-01-01,2013-03-31,2013-05-14 12:21:21+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1886000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1886000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1886000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2809000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8676000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11485000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9599000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,15000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,110000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,95000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9504000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9504000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9504000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9504000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,41300000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,41300000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,41337000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q2,2013-04-01,2013-06-30,2013-08-13 14:37:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,1522000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,1522000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,1522000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2882000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8193000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11075000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9553000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,14000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,134000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,120000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9433000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9433000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9433000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9433000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42900000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42900000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,42839000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q3,2013-07-01,2013-09-30,2013-11-12 13:20:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,725000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,725000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,725000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,2979000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7417000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,10396000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9671000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,13000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,141000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,128000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9543000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9543000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9543000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9543000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,40700000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,40700000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,40916000.0
ChemoCentryx Inc,CCXI,,0001340652,2013.0,Q4,2013-10-01,2013-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3523000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8149000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11672000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11672000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,11000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,146000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,135000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11537000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11537000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11537000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11537000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42700000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42700000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43107000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q1,2014-01-01,2014-03-31,2014-05-09 14:42:26+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3382000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9002000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12384000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12384000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,129000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,123000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12261000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12261000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12261000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12261000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43800000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43800000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43274000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q2,2014-04-01,2014-06-30,2015-08-07 14:08:52+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3510000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7543000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11053000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11053000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,116000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,112000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10941000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10941000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10941000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10941000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43800000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43800000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43336000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q3,2014-07-01,2014-09-30,2015-11-09 16:21:22+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3169000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9121000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12290000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12290000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,103000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12190000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12190000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12190000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12190000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43500000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43500000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43275000.0
ChemoCentryx Inc,CCXI,,0001340652,2014.0,Q4,2014-10-01,2014-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3689000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8420000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12109000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12109000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,103000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,103000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12006000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12006000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12006000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12006000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,42900000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,42900000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43502000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q1,2015-01-01,2015-03-31,2016-05-10 13:04:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3576000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8602000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12178000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12178000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,100000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,100000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12078000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12078000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12078000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12078000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43100000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43100000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43842000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q2,2015-04-01,2015-06-30,2016-08-09 13:44:48+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3811000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,7931000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11742000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11742000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,95000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,95000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11647000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11647000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11647000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11647000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44800000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44800000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44070000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q3,2015-07-01,2015-09-30,2016-11-08 15:46:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3430000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8230000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11660000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11660000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,86000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,86000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11574000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11574000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11574000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11574000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,43890000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,43890000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,43800000.0
ChemoCentryx Inc,CCXI,,0001340652,2015.0,Q4,2015-10-01,2015-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,0.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4084000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,11245000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15329000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15329000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,86000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,86000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15243000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15243000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15243000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15243000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,44800000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.34
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,44800000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.34
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,44277000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q1,2016-01-01,2016-03-31,2017-05-10 16:31:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.34
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2795000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2795000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2795000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3877000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9062000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12939000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-10144000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10144000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10144000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,161000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9983000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9983000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,45400000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,45400000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,45785000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q2,2016-04-01,2016-06-30,2017-08-08 16:23:49+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4251000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4251000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4251000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3193000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,8389000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,11582000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7331000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7331000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7331000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,259000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7072000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7072000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,47100000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,47100000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,47763000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q3,2016-07-01,2016-09-30,2017-11-07 16:53:53+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4889000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4889000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4889000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3556000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9249000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,12805000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7916000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,671000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,671000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-7245000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-7245000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,netincome,otheradjustmentstoconsolidatednetincome,Other Adjustments to Consolidated Net Income / (Loss),+,credit,usd,-420000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-7665000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-7665000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,46432000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,46432000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,46500000.0
ChemoCentryx Inc,CCXI,,0001340652,2016.0,Q4,2016-10-01,2016-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8230000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8230000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8230000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4573000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,9970000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,14543000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6313000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,317000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,317000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-5996000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-5996000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-5996000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-5996000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50000000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.12
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50000000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.12
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48115000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q1,2017-01-01,2017-03-31,2017-05-10 16:31:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.12
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8937000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8937000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8937000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4184000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14329000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,18513000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9576000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,336000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,336000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9240000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9240000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9240000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9240000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48600000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,48600000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48224000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q2,2017-04-01,2017-06-30,2018-08-09 16:28:59+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9029000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9029000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9029000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3624000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12315000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,15939000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-6910000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,350000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,350000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6560000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6560000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6560000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6560000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,50500000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,50500000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48602000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q3,2017-07-01,2017-09-30,2018-11-08 16:32:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,56301000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,56301000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,56301000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4128000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,12881000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,17009000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,39292000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,367000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,363000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,39655000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,39655000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,39655000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,39655000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,48413000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.81
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49615000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.8
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48300000.0
ChemoCentryx Inc,CCXI,,0001340652,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.81
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9546000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9546000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9546000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4660000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,14742000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19402000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9856000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,174000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,613000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,439000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9417000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-9417000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-9417000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-9417000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49600000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49600000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,48853000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q1,2018-01-01,2018-03-31,2019-05-06 16:19:17+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15022000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15022000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15022000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4748000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17759000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22507000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-7485000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,181000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,792000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,611000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-6874000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-6874000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-6874000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-6874000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49100000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.14
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49100000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.14
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,49542000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q2,2018-04-01,2018-06-30,2019-08-05 16:19:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.14
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8975000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8975000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8975000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5373000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15135000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20508000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11533000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,423000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1066000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,643000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10890000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10890000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10890000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10890000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49500000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49500000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50341000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q3,2018-07-01,2018-09-30,2019-11-04 16:28:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9332000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9332000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9332000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5628000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15100000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20728000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11396000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,446000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1057000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,611000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-10785000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-10785000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-10785000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-10785000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,49814000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,49814000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,50000000.0
ChemoCentryx Inc,CCXI,,0001340652,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8327000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8327000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8327000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5501000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15354000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20855000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12528000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,542000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1121000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,579000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11949000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11949000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11949000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11949000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,52000000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,52000000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,52395000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q1,2019-01-01,2019-03-31,2020-05-11 16:44:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7173000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7173000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7173000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5570000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17624000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,23194000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16021000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,547000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1418000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,871000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15150000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15150000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15150000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15150000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58300000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58300000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58056000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q2,2019-04-01,2019-06-30,2019-08-05 16:19:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10581000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10581000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10581000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6116000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18096000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,24212000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13631000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,542000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1311000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,769000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12862000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12862000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12862000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12862000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,58500000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,58500000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,58205000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q3,2019-07-01,2019-09-30,2019-11-04 16:28:28+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10047000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10047000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10047000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6968000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19202000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26170000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16123000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,518000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1113000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,595000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15528000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15528000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15528000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15528000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,56898000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.27
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,56898000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.27
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,56600000.0
ChemoCentryx Inc,CCXI,,0001340652,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.27
